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Abstract
In many biomedical studies with recurrent events, some markers can only be measured when
events happen. For example, medical cost attributed to hospitalization can only incur when
patients are hospitalized. Such marker data are contingent on recurrent events. In this paper, we
present a proportional means model for modelling the markers using the observed covariates
contingent on the recurrent event. We also model the recurrent event via a marginal rate model.
Estimating equations are constructed to derive the point estimators for the parameters in the
proposed models. The estimators are shown to be asymptotically normal. Simulation studies are
conducted to examine the finite-sample properties of the proposed estimators and the proposed
method is applied to a data set from the Vitamin A Community Trial.
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1 Introduction
In many medical studies, patients may experience the same type of event repeatedly over
time. Typical examples of recurrent events include cancer recurrence, multiple infection
episodes, and repeated use of drugs, etc. Although interest usually focuses on the process of
recurrent events, investigators are also interested in outcomes associated with each event, for
example, symptoms at the time of each infection and medical cost incurred at each
hospitalization due to heart attack, etc. We refer to such outcomes as the markers contingent
on recurrent events. In many studies, both the recurrent event itself and the associated
marker are of interest.
A motivating example is from the Vitamin A Community Trial (VACT) conducted in Brazil
(Barreto et al. 1994). The study was a randomized community trial to examine the effect of
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the supplementation of vitamin A on diarrhea morbidity and diarrhea severity in children
living in areas where its intake was inadequate. Some previous studies showed that vitamin
A supplement could reduce children’s mortality by 23–34% in populations where vitamin A
deficiency was endemic. However, the effect on the morbidity was little known before the
study. The VACT study consisted of 1240 children, aged 6–48 months at baseline, who were
assigned to receive either vitamin A or placebo every 4 months for 1 year in a small city in
Northeast Brazil. During the study, a number of children had one or more diarrheal episodes,
where an episode of diarrhea was defined as a sequence of days with diarrhea and the
episode was considered ended if there were 3 or more days without diarrhea. At each
diarrheal episode, the study also collected information on the severity of a diarrheal episode
based on the duration of an episode and a severity scale which was based on the number of
liquid or semi-liquid motions reported in a 24-h period. The severity scale was graded as 1
(mild), 2 (moderate) and 3 (severe). The actual assessment of the severity of one diarrhea
event is the severity score defined as the severity scale multiplied by the length of the
episode. Clearly, this score is a marker process contingent on recurrent diarrhea. For this
study, investigators were particularly interested in answering the following two questions:
(a) Did taking vitamin A reduce the number of diarrheal episodes? (b) Given that a diarrheal
episode occurs, did taking vitamin A lessen the diarrheal severity?
When markers are repeatedly measured and each measurement is associated with the
occurrence of the recurrent event, joint modelling is a natural way to analyze such data.
Research on joint modelling of event data and repeated outcomes has been fruitful in the last
decade, for example, modelling repeated outcomes and a survival endpoint is discussed in
Wu and Bailey (1989), Tsiatis et al. (1995), and Xu and Zeger (2001) among others; while,
modelling repeated outcomes and recurrent events is given in Ratcliffe et al. (2004) and in
Herring and Yang (2007) with an additional terminal event. In these models, subject-specific
random effects are introduced to account for latent dependence between the markers and the
recurrent events and the interpretation of the parameters is dependent on the subject. In
many studies, however, the public health interest focuses on the population-level effects of
risk factors, especially for the studies such as the VACT trial. In such studies, models with
population average interpretation are preferred and joint marginal models may be more
suitable. Joint marginal models have been considered by Lin and Ying (2001) and Hu et al.
(2003), who propose a proportional rates model for the recurrent events and assumed a
marginal means model for the repeated outcomes.
All the aforementioned joint models, either with random effects or marginal models, assume
that the repeated markers and the event time are independent conditional on covariates and/
or subject-specific random effects. Thus, the repeated markers should have the same
distribution at the time of event occurrence as at the time of no event. Obviously, this
assumption is not valid when the repeated markers are actually zeros at the time when no
event occurs. Therefore, none of these approaches is applicable to the VACT trial or medical
cost studies. Furthermore, the parameters introduced in the model for repeated markers in
the joint modelling approach can not directly answer the practical question like (b).
The repeated marker process contingent on recurrent event can also be viewed as a marked
point process, which has been widely used in modelling spatial data (Diggle 2003). The
study of such process usually assumes some Poisson structure (e.g., Martinussen and
Scheike 2000, 2001) and it may lead to biased result if the Poisson structure does not hold.
In this paper, we model the rate of recurrent events and the mean of the marker contingent
on recurrent events. Particularly, a proportional rates model (Lin et al. 2000) is used to
model recurrent event while a proportional means model is used for recurrent markers
contingent on the occurrence of recurrent events. Our models do not need the Poisson
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assumption and the model parameters have direct interpretation to answer questions like (a)
and (b).
In Sect. 2, we provide details of the proposed models. Moreover, we propose an inference
procedure for estimating the effects of covariates. In Sects. 3 and 4, we give the asymptotic
properties of the proposed estimators along with the estimated cumulative marker measure.
We then propose some test statistics for goodness-of-fit in Sect. 5. Simulation studies are
reported in Sect. 6. The proposed method is then applied to data from the VACT study in
Sect. 7. The paper concludes with some remarks in Sect. 8.
2 Models and inference
Suppose X(t) contains all the external covariates. Let N(t) denote the counting process
associated with recurrent events. A marginal model for the rate function of the recurrent
event is assumed to be
(1)
where gr is a known link function and is usually assumed to be exponential. Let m(t) denote
the marker measured at time t and assumed to be positive. Since m(t) only exists when N(t)
has a jump at time t, we propose a conditional mean model for m(t) conditional on N(t) − N(t
−) = 1:
(2)
where gm is another known link function. The link function gm is exponential if the effect of
the covariates on the mean marker accumulation is multiplicative; however, other links such
as the inverted logistic link or linear link can also be useful in some specific contexts.
Models (1) and (2) specify a very general class of models. It includes a general class of
frailty models as special cases. To see this, suppose ξ(t) denote the subject specific frailty
process independent of X. Assume that the recurrent events follow the frailty model
where ψ1(·, ·) is a bivariate function. Since the marker is associated with the recurrent event,
it may also be natural to assume ξ affects the mean of m(t). Then we can assume
where ψ2(·, ·) is another bivariate function. It is easy to show
Moreover,
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Therefore, the assumed frailty models imply models (1) and (2) but with different baseline
functions, i.e., the assumed frailty models are special cases of models (1) and (2). In this
paper, we work with the general case as specified in models (1) and (2).
In the presence of censoring, the observations from n i.i.d subjects are
where ΔNi(t) = Ni(t) − Ni(t−) and Ci is the censoring time and is assumed to be non-
informative of Ni(t) and mi(t) given covariates. To make inference on β and γ, from (1) and
following Lin et al. (2000), we first estimate β using the following estimating equation
(3)
where Ri(t) = I(Ci > t) is the at-risk process for subject i and  denotes the derivative of
gr(x). We denote β̂ as the solution to (3).
To estimate γ, from Eqs. 1 and 2, if we define the cumulative marker at time t as
(4)
where m(t) is the marker measured at time t whenever an event occurs at time t, then we
obtain
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The above expression is another type of rate model similar to (1) if we redefine μ(t)λ(t) =
v(t). Using the same idea of constructing estimating equation for the recurrent event, we
treat  as a step function with jumps at the observed events. We then propose
the following estimating equations for estimating V(t) and γ:
From the first equation, we obtain
After plugging this expression into the second equation for γ, we have that the estimate for
γ, denoted by γ̂, solves
(5)
3 Asymptotic properties
We need the following assumptions.
(C1) Let τ be the study duration. We assume Pr(C ≥ τ|X) > 0.
(C2) Covariate X(t) is a bounded function with finite total variation in [0, τ].
(C3) Both gr(·) and gm(·) are twice-continuously differentiable and strictly positive.
(C4) Let
with the superscripts denoting the derivatives. Assume that both matrix
and matrix
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Condition (C1) assumes that there is a positive chance of observing the entire event process
till time τ. Condition (C3) includes a number of choices of link functions. When gr(x) =
gm(x) = exp(x), condition (C4) is similar to the standard condition in the proportional
hazards model. Under these conditions, the following theorem holds.
Theorem 1
Under conditions (C1)–(C4),  converges in distribution to a normal
distribution with mean zero.
Let  denote the underlying probability measure and [Q] = E[Q] for any random variable
Q. Correspondingly, let n denote the empirical measure based on n observations. The proof
of Theorem 1 is mainly based on the linearization of Eq. 3 and use the weak convergence of
. The details are given in the appendix. Particularly, the proof of Theorem 1
yields that the asymptotic covariance for  is equal to
where
and
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Therefore, a consistent estimator for the asymptotic covariance can be given by
where Σ̂kl, k, l = 1, 2, Ŝβ and Ŝγ are defined as in the above expressions but with  replaced
by n and the true parameters replaced by their estimators.
4 Estimation of cumulative recurrent marker
In many applications, such as in studies to assess recurrent severity score or recurrent
medical cost, one may also be interested in estimating the total marker by a fixed time s for s
≤ τ, i.e., E[M(s)].
From the proposed estimation method in Sect. 2, we can estimate this quantity by
The following theorem describes the large sample property of M ̂(s).
Theorem 2
Under conditions (C1)–(C4),  converges in distribution to a mean-zero
Gaussian process, denoted as , in l∞[0, τ].
The proof is given in the appendix. Moreover, from the proof, we obtain
where ℐ(Ri, Mi, Xi, s; , β0, γ0) is the influence function of M ̂(s) as given in the proof. Thus,
we can construct the confidence band for E[M(s)] for s ∈ [0, τ] using the Monte-Carlo
method. Specifically, we generate Q = (Q1, …, Qn) independently from the standard normal
distribution. We then calculate
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We repeat this process B times for a large number B. Then the collection of M ̂Q(s) from B
repetitions simulates the limiting process of M ̂(s). Particularly, we have the following result.
Theorem 3
Under conditions (C1)–(C4), conditional on the observed data,  converges
in distribution to .
As the result, we can use the simulated process M ̂Q(s) to construct the confidence band for
E[M(s)]. For example, a pointwise (1−α)-level confidence band for E[M(s)] can be obtained
by
where zα/2(s) and z1−α/2(s) are the α/2 and (1−α/2)th quantiles of {M ̂Q(s)−M ̂(s)}
respectively.
5 Test for goodness-of-fit
One important issue in models (1) and (2) is the choice of link functions gr and gm.
Therefore, in this section, we propose some goodness-of-fit test statistics for the model. The
construction of our test is based on the fact that when the correct link functions are used,
both processes,
and
are mean-zero processes given covariates. Hence, we consider the following two statistics
and
where β̂ and γ̂ are the estimates given in Sect. 2, and
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Intuitively, these two processes accumulate the marginal residuals based on the linear
predictors so the departure from zeros may imply that the link functions between the
observed recurrent events or the markers and the linear predictors are chosen incorrectly.
The following theorem describes the asymptotic behavior of 1(x) and 2(y).
Theorem 4
Under models (1) and (2) and conditions (C1)–(C4),  weakly converges to a
bivariate Gaussian process in l∞(R2) with mean zero.
The proof of the theorem is provided in the appendix. From the Proof of Theorem 4, we
obtain
and both S1(R, M, X, x) and S2(R, M, X, y) can be estimated consistently by Ŝ1(R, M, X, x)
and Ŝ2(R, M, X, y). Therefore, we can use the same idea in the previous section to simulate
the limiting Gaussian process: We generate Q = (Q1, …, Qn) independently from the
standard normal distribution, then calculate
. The simulated process after
repeating this procedure many times approximates the limiting Gaussian process. The proof
is similar to those used for Theorem 3.
With Theorem 4, we can construct any summary statistics of the proposed processes ( 1(x),
2(y))T, for example, the maximal norm or L2-norm of these two processes. Then by
simulating the limiting process under the null hypothesis that correct link functions are used,
we are able to construct a valid test for testing the null hypothesis.
6 Simulation studies
Two simulation studies are conducted to examine the finite-sample performance of the
proposed approach. In both simulation studies, we consider two independent covariates X1
and X2 where X1 is from the uniform distribution in [0, 1] and X2 is a Bernoulli variable with
equal probabilities at 0 and 1. The recurrent events are generated from the following
intensity function
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where ξ denotes the subject-specific frailty and follows Gamma(2,2), β1 = −1, and β2 = 1. At
each occurred event, the marker process m(t) satisfies
where ε follows the standard normal distribution, γ1 = 0.5, γ2 = 0.8, and ρ describes the
association between the marker and the events due to the frailty. As discussed before, the
above two models imply models (1) and (2). We consider ρ = 0 and ρ = 1/2. The link
function gm is taken to be the exponential link in the first simulation study, i.e., gm(x) =
exp{x}, and in the second simulations study, gm(x) = (1 + x)2. The censoring time is
generated from the uniform distribution in [0, 3] so τ = 3, which yields an average of 3.5
events per subject. The true value for E[M(3)] is 55.421 in the first simulation study and
78.983 in the second one.
Table 1 summarizes the simulation results from 1000 repetitions with different sample sizes.
From Table 1, we conclude that the proposed method performs well in finite sample: the
bias of the estimators for β’s is almost negligible while the relative bias for γ’s is within 5%
for sample size 200 and decreases significantly for sample size 400; the estimated standard
errors agree well with the empirical standard errors with the maximal difference less than
5% with sample size 400; the confidence interval for estimating these parameters has proper
coverage. Table 1 also shows that the estimates for the cumulative marker have very small
bias and the inference seems to be accurate. In the simulation studies, we also evaluate the
performance of the proposed goodness-of-fit test statistics. The Type I error rates for maxx |
1(x)| are all close to 0.05 for each setting in Table 1; the type I error rates for maxx | 2(x) |
is conservatively around 0.03 for sample size 200 but range between 0.045 and 0.052 when
the sample size increases to 400. This suggests that the proposed tests are valid with sample
size 400. We also conduct simulations where the baseline function is 0.5 exp(0.2t) (results
not shown). The performance is also good and the conclusions are similar.
Additionally, we conduct simulation studies to examine the robustness of our estimators
when the link function in the model for the recurrent marker is misspecified. Particularly, we
generate the recurrent events and the marker data as before; however, the true link function
for generating the marker at each event is gm(x) = (1 + x)2 while we misspecify it as the
exponential link in estimation. Table 2 summarizes the results from 1000 repetitions. From
the table, we find that the missepcification of the link function causes a large bias in
estimating the effects of the covariates on the marker, especially for the dichotomous
covariate X2. However, even if we use the wrong link function, the estimates for the
cumulative marker have negligible bias and their inference is also accurate. For this
simulation study, we also calculate the power based on 2 and it turns out to be low,
suggesting that the misspecified links, although affect the regression parameter estimates,
have little influence on the overall fit of the data. This may also explain why the estimates
for the cumulative marker are robust to the misspecification of the link function.
7 Application
We apply our method to analyze the VACT data. Besides the covariate for treatment
assignment, other covariates include children’s baseline age and gender. The average
number of days of follow-up is 331 days, with 83.7% of the children having daily
continuous information for one year. A total of 1063 children had at least one diarrheal
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episode during their follow-up period in the study and the average number of episodes is 5.9.
The first half in Table 3 summarizes this information in both treatment group and placebo
group. To assess the severity, we calculate the severity score at each episode as the severity
scale (1,2,3) multiplied by the number of duration days in this episode. The summary
information for this severity score is reported in the second half of Table 3.
We use models (1) and (2) for the recurrent events and the severity scores respectively.
Particularly, we use the exponential link in model (1) while consider either exponential or
square links in model (2). The results given in Table 4 show that using vitamin A
supplement may reduce the risk of recurrent diarrhea and such reduction is marginally
significant; using vitamin A supplement did not reduce the diarrheal severity. The older
children tended to have lower risk of both diarrheal recurrence and less severe diarrhea.
There appears to be no difference between boys and girls. Finally, we also calculate the
estimates for the total severity measurement in treatment group and placebo group. Under
the exponential link, the two estimates are respectively 53.96 and 60.12. The test based on
the asymptotic normal distribution yields a p-value of 0.27. Thus, it indicates that, overall,
the vitamin A supplement does not significantly reduce the total severity. These results are
very close to the results when the square link function is used. Figure 1 plots the estimated
cumulative severity score as a function of time in the two groups along with the pointwise
confidence bands. It shows that overall, the treatment group tends to have less severe
episodes as compared to the placebo group; however, such difference is not statistically
significant.
To compare the exponential link versus the square link, we apply the goodness-of-fit test
proposed in Sect. 5. The resulting processes are given in Fig. 2. Especially, subplot (a)
presents the estimated process 2(x) versus the percentiles of the linear predictors XT γ
along with 10 simulated curves from the limiting distribution when the exponential link is
used for fitting marker data; while subplot (b) presents the same processes under the square
link. Note that the value for the estimate of γ is different with different link functions which
results in different scale in x-axes. The figure shows that the patterns under these two
different links are very similar. We further calculate the p-values based on the maximal-
norm and find that the p-value associated with the exponential link is 0.66 and the p-value
associated with the square link is 0.75. This indicates that there is no strong evidence to
reject either link, i.e., essentially they both fit data well.
8 Remarks
We have proposed a semiparametric proportional means model for marker data contingent
on recurrent events. Our estimates provide insight on the effects of risk factors on both the
recurrent event process and the marker associated with the recurrent event. We have applied
this approach to the Vitamin A Community Trial. We note that many other medical
applications can fall under this framework.
In some applications, when one is particularly interested in prediction, frailty model can be
useful. Under such situation, random frailty can be introduced in modelling recurrent events
and markers to account for within-subject variation. Particularly, one can model the intensity
of recurrent events and the conditional distribution of recurrent markers at each event.
Inference for this semiparametric model is feasible but requires more delicate justification.
Further generalization of our setting will include informative censoring and informative
marker data. Additionally, using more general transformation models as in Lin et al. (2001)
for recurrent events and recurrent markers is also possible.
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Appendix
Proof of Theorem 1
For convenience, we introduce n and  as the empirical measure and the true measure
respectively. The empirical process n is defined as . Then Eq. 3 can be
expressed as
In any neighborhood of β0, by the Glivenko–Cantelli theorem (van der Vaart and Wellner
1996, Chap. 2.3), with probability one, the left-hand side uniformly converges to
Since
and by the assumptions, Σ11 is non-singular, we have
By the degree theory (Deming 1985, Chap. 1), the inequality implies
has the same number of zero-solution as Σ11(β − β0) within |β − β0| ≤ ε which has only one
solution. That is, there exists β̂ solving Eq. 3 and |β̂ − β0| ≤ ε when n is larger enough. We
have proved the consistency of β̂.
From Eq. 3, using the Donsker property of gr(X(t)T β), we obtain
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where Sβ is defined before. As the result, β̂ is an asymptotically linear estimator for β0 with
influence function .
Similarly, we can show that there exists a solution γ̂ to Eq. 5 and γ̂ converges to γ0 almost
surely. From the Donsker property of the arguments, Eq. 5 implies
The Taylor expansion of the first term of the right-hand side yields
Therefore, γ̂ is an asymptotically linear estimator for γ0 with influence function
Hence, we conclude that  converges in distribution to normal distribution
with mean zero and covariance equal to
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Clearly, a consistent estimator for this asymptotic covariance can be given by replacing 
with n in the expressions of Σ11, Σ12, Σ22, Sβ and Sγ.
Proof of Theorem 2
We wish to derive the asymptotic distribution for M ̂(s). Following the same argument as
before, we obtain
where op(1) is in the metric space l∞[0, τ]. Hence, the asymptotic Gaussian property for M ̂
(s) thus follows.
Additionally, we obtain the influence function for M ̂(s) as
Proof of Theorem 3
By Theorem 3.6.13 (van der Vaart and Wellner 1996), since ℐ(R, M, X, s; n, β̂, γ̂) belongs
to a Donsker class and Var(Q) = 1, conditional on the observed data,
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Proof of Theorem 4
Following the same expansions as given in proving Theorems 2 and 3, we obtain
Similarly,
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It is easy to verify (S1(R, M, X, x), S2(R, M, X, y)) belong to some Donsker classes in l∞(R2).
Therefore,  weakly converges to a mean-zero Gaussian process in l∞(R2).
Particulary, the asymptotic covariance of this process is given by
Clearly, both S1(R, M, X, x) and S2(R, M, X, y) are consistently estimated if we replace
expectation with empirical expression in S1(R, M, X, x) and S2(R, M, X, y) and replace (β0,
γ0, Λ0, V0) with their corresponding estimates.
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Estimated cumulative severity score over time in VACT study: the upper solid curve is the
estimated cumulative severity score in the placebo group and the lower solid curve is the
estimated cumulative severity score in the treatment group. The dashed curves are the 95%
point-wise confidence bands
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Test for goodness-of-fit. a corresponds to the exponential link and b corresponds to the
square link. The x-axes correspond to linear predictors. The solid lines are the test statistics
and the dashed lines are the curves simulated from the limiting distributions
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Table 3
Summary of diarrheal episodes and severity in VACT data






≥ 16 39 45
Total severity scores
(0, 50) 419 395
[50, 100) 89 101
[100, 200) 72 69
[200, ∞) 25 37
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